Market news

LifeMD, Inc. (NASDAQ:LFMD) announced an exclusive healthcare collaboration on September 15 that initially makes virtual-health membership benefits available to approximately 29 million eligible AT&T wireless and fiber customers across 11 states. Customers must be 18 or older, and some services have additional eligibility and state restrictions. A nationwide expansion planned for January 2027 would extend […]

T expands customer benefits with complimentary LifeMD memberships, offering virtual care, prescriptions and pharmacy services.

Detailed price information for AT&T Inc (T-N) from The Globe and Mail including charting and trades.

LifeMD is back in focus after fair value in the updated model shifted from US$9.88 to US$8.13, an adjustment of about 18% that aligns with lower Street price targets in recent research. Analysts have been resetting expectations following the latest Q2 report and guidance, with some still pointing to long term growth drivers while acknowledging nearer term pressure on revenue and earnings outlooks. In the sections that follow, you will see how this evolving narrative around LifeMD might shape...

LifeMD trades at a historically low 0.75x TTM revenue multiple amid a 48% one-year share price decline.

Tipranks Press Release.

Detailed price information for General Motors Company (GM-N) from The Globe and Mail including charting and trades.

Detailed price information for Lifemd Inc (LFMD-Q) from The Globe and Mail including charting and trades.

LifeMD (LFMD) delivered earnings and revenue surprises of +20.00% and -3.70%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

UPDATE this press release has been updated to remove a duplicate table. Second quarter 2026 revenue of $47.3 million, within the Company’s guidance range of $47 million to $50 million; adjusted EBITDA loss of approximately $3.5 million, improving approximately 21% sequentially.Approximately 95% of all new weight management patients now begin treatment with branded GLP-1 therapies; with the guidance provided today, the Company believes it is effectively at the end of its transition away from comp

LifeMD (NASDAQ:LFMD) reported second-quarter revenue of $47.3 million, within its prior guidance range, while posting an adjusted EBITDA loss of approximately $3.5 million as elevated customer acquisition costs and a lower introductory price for branded GLP-1 care pressured profitability. Chairman

Conference call begins at 4:30 p.m. Eastern time today

At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life.

NEW YORK, July 24, 2026 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, announces that it will report financial results for the three and six months ended June 30, 2026, after the close of the U.S. financial markets on August 5, 2026, and will host a conference call beginning at 4:30 p.m. Eastern time. Conference Call & Webcast Details Date:Wednesday, August 5thTime:4:30 p.m. Eastern timeToll-Free Dial-In:(800) 715-9871International Dial-In:+

About This EventLifeMD (Nasdaq: LFMD), a leading national provider of virtual healthcare and pharmacy services, visits the Nasdaq MarketSite in Times Square.In honor of the occasion, Stefan Galluppi and Justin Schreiber, the Co-Founders of LifeMD ring the Closing Bell.